As Republican lawmakers look for ways to cut spending, many are worried about potential cuts to Medicaid funding that helps Americans struggling with opioid addiction. A recent report from the Congressional Joint Economic Committee highlights that more than a million people in the U.S. rely on Medicaid for treatment of opioid use, including those affected by the fentanyl crisis.
Senator Maggie Hassan from New Hampshire expressed concern, stating that proposed cuts to Medicaid could endanger addiction care just as progress is being made in tackling the fentanyl issue. Over the past decade, Medicaid has become a vital source of insurance for high-quality addiction treatment, especially after many states expanded coverage under the Affordable Care Act.
A February study from the Brookings Institution found that nearly 90% of opioid and fentanyl addiction treatment in the U.S. is funded, at least in part, by Medicaid. This funding has been credited with helping to reduce drug overdose deaths, which recently fell by 26.6% nationwide, according to the Centers for Disease Control and Prevention.
Despite these positive outcomes, many Republican lawmakers remain skeptical of the Affordable Care Act. There is uncertainty about how their budget proposals will affect Medicaid and its role in addiction treatment. Some House GOP leaders have suggested cutting as much as $2.3 trillion from the program over the next decade.
House Speaker Mike Johnson recently stated that he believes young, able-bodied men should not qualify for Medicaid. Research shows that men are significantly more likely to die from drug overdoses, with fentanyl being a leading cause of death for men under fifty.
Experts in addiction treatment are sounding alarms about the potential impact of deep Medicaid cuts. They worry that such reductions could hinder the national recovery from the fentanyl epidemic. Dr. Brian Hurley, president of the American Society of Addiction Medicine, urged lawmakers to protect Medicaid expansion, emphasizing its importance in funding evidence-based treatment and reducing demand for illicit opioids.
The Brookings report warns that significant cuts to Medicaid could lead to a drastic reduction in addiction care across the country. It notes that Medicaid funding for opioid use disorder treatment far exceeds all other public funding sources. Reductions in this area would greatly diminish the U.S. commitment to addressing the opioid crisis.